Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05408559 · ClinicalTrials.gov registry record · Phase 1
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
A Phase 1 study of Diastolic Heart Failure and Diastolic Dysfunction, sponsored by Texas Tech University Health Sciences Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05408559 is a Phase 1 study of Diastolic Heart Failure and Diastolic Dysfunction that is actively recruiting participants, run by Texas Tech University Health Sciences Center. The registered enrollment target is 200 participants, below the 381-participant average among 7 other Diastolic Heart Failure trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05408559, a Phase 1 study of Diastolic Heart Failure and Diastolic Dysfunction, is actively recruiting participants, sponsored by Texas Tech University Health Sciences Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Our local IRB approved clinical studies seeking proof of principle for the hypothesis that SFN can be safely administered to humans at doses sufficient to protect age-associated cardiac dysfunctions. Beneficial effects of SFN-therapy will be assessed by Pre- and post-intervention echocardiography, and exercise endurance at 0 and 24 weeks. Peripheral blood cells from treated and control subjects will be compared for mitochondrial respiratory function, oxidative damage, pro-inflammatory cytokines, and expression of antioxidant \& anti-electrophile genes.
Conditions Studied
Interventions
- DRUG Sulforaphane
Study Locations (1)
Texas
- Texas Tech University Health Sciences Center (TTUHSC) - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-07-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05408559
The ClinicalTrials.gov registry entry for NCT05408559 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 381-participant average among 7 other Diastolic Heart Failure trials with a reported enrollment target (48% lower). The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diastolic Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Sulforaphane is the first listed.
NCT05408559 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05408559 about?
NCT05408559 is a clinical study titled "Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES". Our local IRB approved clinical studies seeking proof of principle for the hypothesis that SFN can be safely administered to humans at doses sufficient to protect age-associated cardiac dysfunctions. Beneficial effects of SFN-therapy will be assessed by Pre- and post-intervention echocardiography, a...
What is the current status of trial NCT05408559?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2022-07-01. Estimated completion is 2026-07-30.
What conditions does trial NCT05408559 study?
This clinical trial studies the following conditions: Diastolic Heart Failure, Diastolic Dysfunction, Systolic Dysfunction.
What interventions are being tested in trial NCT05408559?
The interventions under investigation include: Sulforaphane (DRUG).
Who is sponsoring clinical trial NCT05408559?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05408559 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diastolic Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
COMPLETED · Phase 1
-
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
RECRUITING · Phase 4
-
Purinergic Signaling and the Postmenopausal Heart
RECRUITING
-
Assessment of CCM in HF With Higher Ejection Fraction
RECRUITING · NA
-
A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure
COMPLETED · Phase 2
-
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.